Posted on December 1, 2021 by Sitemaster
In late October, we had commented on the then-latest revision of the National Comprehensive Cancer Network (NCCN)’s guidelines on the initial management of men with low-risk forms of localized prostate cancer. Specifically we had protested the removal of any suggestion that this form of prostate cancer should — preferably — be managed using active surveillance. The NCCN has now released a new revision to the guidelines that has modified the prior suggestion. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, guidelines, low-risk, NCCN, surveillance | 4 Comments »
Posted on October 20, 2021 by Sitemaster
As many readers will already be aware, the National Comprehensive Cancer Network (NCCN) has recently removed the word “preferred” from its statement regarding the use of active surveillance (AS) as an appropriate form of management of men with low-risk forms of localized prostate cancer. A broad swath of specialists in the initial management of low-risk disease, as well as many in the patient advocacy community, have been highly critical of this change to the NCCN guidelines. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: active, guidelines, low-risk, NCCN, surveillance | 10 Comments »
Posted on February 20, 2018 by Sitemaster
As it does at least once a year, the National Comprehensive Cancer Network (NCCN) has just released version 1.2018 of its guidelines for physicians on the management of prostate cancer. … READ MORE …
Filed under: Management, Treatment | Tagged: guideline, NCCN, update | 4 Comments »
Posted on January 8, 2016 by Sitemaster
Posted on October 19, 2015 by Sitemaster
Last Friday, the National Comprehensive Cancer Cancer Network (NCCN) introduced a new way for doctors and patients to be able to consider the clinical “value” of treatment with specific drugs in specific forms of cancer. How useful this method is will take a while to work out. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: affordability, efficacy, evidence, guideline, NCCN, safety, value | Leave a comment »
Posted on March 19, 2013 by Sitemaster
According to a report on the Medscape Oncology web site this morning, the National Comprehensive Cancer Network (NCCN) has just released, for the first time, guidelines for clinicians that address factors affecting “survivorship” after a diagnosis of and treatment for cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Uncategorized | Tagged: guidelines, NCCN, survivorship | Leave a comment »
Posted on December 26, 2011 by Sitemaster
We have now had the chance to look carefully through the new, patient-specific guidelines on prostate cancer issued by the National Comprehensive Cancer Network (NCCN) just before the Holidays. They are not perfect, but they are certainly a vast improvement over the NCCN’s first attempt. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: Diagnosis, guideline, Management, NCCN, patient, risk | 16 Comments »
Posted on December 23, 2011 by Sitemaster
The “New” Prostate Cancer InfoLink is pleased to see that — here in the USA — the National Comprehensive Cancer Network (NCCN) has just issued a fully revised, new edition of the NCCN Guidelines for Patients™ for Prostate Cancer (Version 1.2011). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: edition, guideline, NCCN, new, patient | 5 Comments »
Posted on January 2, 2011 by Sitemaster
Posted on May 29, 2010 by Sitemaster
The National Comprehensive Cancer Network has updated its prostate cancer management guidelines to give a category 1 recommendation for clinical use of sipuleucel-T (Provenge) in the treatment of selected patients. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: guidelines, NCCN, Provenge, sipuleucel-T | Leave a comment »
Posted on March 18, 2010 by Sitemaster
In a long media release today, the National Comprehensive Cancer Network (NCCN) encapsulated a presentation at the NCCN’s 15th Annual Conference by Dr. James L. Mohler, in which he discussed the role of active surveillance and other treatment options recommended in the recently updated NCCN Guidelines™ for Prostate Cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active surveillance, guidelines, NCCN, Treatment | Leave a comment »
Posted on January 15, 2010 by Sitemaster
Last week we reported on the new NCCN guidance on prostate cancer management, including the heavy emphasis on active surveillance as a first-line treatment option for as many as 40 percent of men newly diagnosed with prostate cancer. Today a new article on Medscape also takes up this issue, with views from a select group of physicians on issues that relate to the implementation of this new guidance.
Filed under: Management, Treatment | Tagged: active surveillance, guideline, NCCN | 3 Comments »
Posted on January 7, 2010 by Sitemaster
In a media release issued earlier today, the National Comprehensive Cancer Network (NCCN) has announced updates to the NCCN Clinical Practice Guidelines for Oncology™ for Prostate Cancer, and has placed a new emphasis on the value of active surveillance in management of men with low and very low risk of clinically significant disease. … READ MORE …
Filed under: Management, Treatment, Uncategorized | Tagged: active surveillance, guidelines, National Comprehensive Cancer Network, NCCN | 7 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 